ArticleDrug delivery and translational research2024

Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis.

Amr Gamal Fouad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.